Skip to main content
BrainCited

Ginkgo biloba 用于 Age-Related Cognitive Decline

C

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

结论

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

Key Study Findings

Review
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?
Dose: None vs: placebo Outcome: cognitive assessment scores (MMSE, SKT, NPI) 效果: None None

研究人群: patients with mild-to-moderate Alzheimer disease or vascular dementia

Review
Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.
Dose: None vs: None Outcome: None 效果: None None

研究人群: patients with vascular cognitive impairment and dementia

Review
The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Review of natural products for neuroprotection

Review
Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review.
Dose: None vs: None Outcome: Cognitive function in multiple sclerosis 效果: None None

研究人群: Multiple sclerosis patients (review)

Review
Nutritional strategies against dementia in rural populations.
Dose: None vs: None Outcome: None 效果: None None

研究人群: Rural populations with dementia risk

Cohort Study n=64 52 weeks Open-label
Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment.
Dose: 240 mg/day vs: Standard cognitive enhancers Outcome: Cognitive responder rate and AD conversion 效果: 100% vs 59.1% responders; 0% vs 13.6% AD conversio <0.001 (responders); 0.037 (AD

研究人群: Amyloid PET-positive MCI patients

Key Statistics

40

研究数量

8000

受试者

Mixed

C

等级

Referenced Papers

Pharmaceuticals (Basel, Switzerland) 2021 33 次引用
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2020 4 次引用
Acta bio-medica : … 2018 103 次引用
Journal of Alzheimer's … 2017 17 次引用
Age (Dordrecht, Netherlands) 2014
American family physician 2011
JAMA 2010 3 次引用
The Practitioner 2010
The Cochrane database … 2009 299 次引用
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 次引用
The Proceedings of … 2002 191 次引用
The Cochrane database … 2002
Current opinion in … 1998 30 次引用
British journal of … 1993 8 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

上限: 600 mg/day (doses above show no additional benefit)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
240 mg/day 52 weeks Positive 64
None -- Positive --
None -- Neutral --

最佳服用时间: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

已报告的副作用

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

已知相互作用

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

可耐受最高摄入量: 600 mg/day (doses above show no additional benefit)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Ginkgo biloba help with Age-Related Cognitive Decline?
Based on 40 studies with 8,000 participants, there is limited but promising evidence that Ginkgo biloba may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Ginkgo biloba should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 40 peer-reviewed studies with 8,000 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。